Population Genetics Technologies (PGT)
PGT was founded in 2005 by Nobel Laureate Sydney Brenner and his colleagues Sam Eletr and Philip Goelet. Their vision was to create and commercialize nucleic acid biochemistry tools and approaches, referred to as “chemware” by Sydney, that would contribute to a better understanding of the inherent complexity of human, animal, plant and microbiological genomes. The founders realized that useful applications of genomic information would require acquiring and processing data from large numbers of samples of a population in order to draw statistically valid inferences about the role of genetics as a cause of traits or disease. To advance this vision, the Company from its inception focused its efforts on developing novel concepts that would take advantage of the enormous throughput of next generation sequencing (NGS) in the most efficient possible manner. Since PGT’s founding, a broad portfolio of over 30 patents have issued in the US, EU and other major markets.
PGT is currently selling certain intellectual property families within its portfolio, targetting leading companies in the molecular diagnostic and broader sequencing and life science tools sectors that have the capabilities and resources to bring the technologies to market and through, where needed, the required regulatory approval.